by Admin | Jun 15, 2021 | News & Opinions
The International Space Station (ISS) U.S. National Laboratory will host a panel of industry experts on the impacts of health, aging, and human survival research onboard the orbiting laboratory at the World Stem Cell Summit. This annual event brings together noted...
by Admin | Jun 14, 2021 | News & Opinions
SenlangBio, a world-class cell therapy company, has developed a robust pipeline which includes 15 autologous and universal (“off-the-shelf”) CAR-T and CAR-γδT cell therapy candidates targeting hematologic malignancies and solid tumors SenlangBio’s lead CAR-T...
by Admin | Jun 11, 2021 | News & Opinions
FREEHOLD, N.J., June 11, 2021 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it will be presenting at the Noble Capital Markets...
by Admin | Jun 8, 2021 | News & Opinions
FREEHOLD, N.J., June 08, 2021 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announces that the company’s President and Chief Executive...
by Admin | Jun 8, 2021 | News & Opinions, Science
Durham, NC – Critically ill COVID-19 patients treated with non-altered stem cells from umbilical cord connective tissue were more than twice as likely to survive as those who did not have the treatment, according to a study published today in STEM CELLS Translational...
by Admin | Jun 7, 2021 | News & Opinions
June 4, 2021 – By Susan Buckles – (link to article) – Julie Allickson, Ph.D., has been named the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine and the Otto Bremer Trust Director, Biomanufacturing and...
